Amlodipine Besylate Tablet
Product Images NDC 71335-2507

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 71335-2507). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Amlodipine Besylate (99f197ee 0a14 4981 A816 A1570a5a8da7 01)

Amlodipine Besylate (99f197ee 0a14 4981 A816 A1570a5a8da7 01)
Chemical structure of Amlodipine Besylate, showing its molecular composition including aromatic rings, methoxy groups, and a benzenesulfonic acid component.*
FDA Label Image

Figure 1 (Kaplan-Meier Analysis of Composite Clinical Outcomes for Amlodipine versus Placebo)

Figure 1 (Kaplan-Meier Analysis of Composite Clinical Outcomes for Amlodipine versus Placebo)
Kaplan-Meier survival curve comparing composite clinical outcomes between Amlodipine and placebo groups over 24 months. The graph shows event rates on the y-axis and time in months on the x-axis, with Amlodipine having a lower event rate than placebo. Indicates statistical measures including p-value, hazard ratio, and confidence interval.*
FDA Label Image

Figure 2 (Effects on Primary Endpoint of Amlodipine versus Placebo across Sub-Groups)

Figure 2 (Effects on Primary Endpoint of Amlodipine versus Placebo across Sub-Groups)
A forest plot showing hazard ratios with 95% confidence intervals comparing Amlodipine versus placebo effects across various patient subgroups, including overall population, age groups (<65 and ≥65), gender, baseline sitting systolic blood pressure, baseline vessel disease, baseline vessels with stenosis, and PCI-stent strata. The plot visually indicates whether results favor Amlodipine or placebo along the horizontal axis.*
FDA Label Image

Label (Lbl713352507)

Label (Lbl713352507)
Label for Amlodipine Besylate 10 mg oral tablets, USP, supplied in a package of 30 tablets. The label states the product is repackaged by Bryant Ranch Prepack and manufactured by Lupin Limited. It includes storage instructions, overdose warning, a QR code for package insert, and barcodes including the NDC 71335-2507-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.